Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary

Cancer Epidemiology

Volumn 36, Issue 5, 2012, Pages 470-475

  Han, Anqin ^a,b   Xue, Jie ^c   Hu, Man ^a,b   Zheng, Jinsong ^b   Wang, Xiaohui ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma of unknown primary; Fluorodeoxyglucose; Positron emission tomography; Primary tumor detection

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; BREAST TUMOR; CANCER OF UNKNOWN PRIMARY SITE; COLON TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; OVARY TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR; UROGENITAL TRACT TUMOR; WHOLE BODY SCINTISCANNING; ANGIOSARCOMA; CANCER STAGING; CARCINOMA; CASE REPORT; DIGESTIVE SYSTEM TUMOR; EVALUATION; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; URINARY TRACT CANCER;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 84865865074     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.03.002     Document Type: Article

References (24)

1. Antoch G., Saoudi N., Kuehl H., Dahmen G., Mueller S.P., Beyer T., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004, 22(21):4357-4368.
2. Macdonald K., Searle J., Lyburn I. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5. Clin Radiol 2011, 66(3):244-250.
3. Shum W.Y., Hsieh T.C., Yeh J.J., Chen J.H., Su C.C., Liang J.A., et al. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma. Eur J Radiol 2011.
4. Xiu Y., Bhutani C., Dhurairaj T., Yu J.Q., Dadparvar S., Reddy S., et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med 2007, 32(2):101-105.
5. Hu Q., Wang W., Zhong X., Yuan S., Fu Z., Guo H., et al. Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer. Eur J Radiol 2009, 70(2):320-324.
6. Pavlidis N., Fizazi K. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009, 69(3):271-278.
7. Roh J.L., Kim J.S., Lee J.H., Cho K.J., Choi S.H., Nam S.Y., et al. Utility of combined (18) F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol. 2009, 45(3):218-224.
8. Nassenstein K., Veit-Haibach P., Stergar H., Gutzeit A., Freudenberg L., Kuehl H., et al. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography. Acta Radiol. 2007, 1-8.
9. Hu M., Zhao W., Zhang P.L., Ju G.F., Fu Z., Zhang G.L., et al. Clinical applications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary. Chin Med J (Engl) 2011, 124(7):1010-1014.
10. deWouw A.J.v., Jansen R.L., Speel E.J., Hillen H.F. The unknown biology of the unknown primary tumour: a literature review. Ann Oncol 2003, 14(2):191-196.
11. Pavlidis N., Pentheroudakis G. Cancer of unknown primary site: 20 questions to be answered. Ann Oncol 2010, 21(Suppl. 7):vii303-vii307.
12. Kwee T.C., Basu S., Cheng G., Alavi A. FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2010, 37(3):635-644.
13. Rohren E.M., Turkington T.G., Coleman R.E. Clinical applications of PET in oncology. Radiology 2004, 231(2):305-332.
14. Al-Brahim N., Ross C., Carter B., Chorneyko K. The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center. Ann Diagn Pathol 2005, 9(2):77-80.
15. Blaszyk H., Hartmann A., Bjornsson J. Cancer of unknown primary: clinicopathologic correlations. APMIS 2003, 111(12):1089-1094.
16. Werner J.A., Dunne A.A., Myers J.N. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck 2003, 25(4):322-332.
17. Kaya A.O., Coskun U., Unlu M., Akdemir U.O., Ozdemir N.Y., Zengin N., et al. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin. Asian Pac J Cancer Prev 2008, 9(4):683-686.
18. Shinya T., Rai K., Okumura Y., Fujiwara K., Yonei T., Sato T., et al. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes inpatients with non-small cell lung cancer. Clin Nucl Med 2009, 34(4):216-221.
19. Uesaka D., Demura Y., Ishizaki T., Ameshima S., Miyamori I., Sasaki M., et al. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lungcancer. J Nucl Med 2008, 49(10):1606-1612.
20. Hu Q., Wang W., Zhong X., Yuan S., Fu Z., Guo H., et al. Dual-time-point FDG PET for the evaluation of loco regional lymph nodes in thoracic esophageal squamous cell cancer. Eur J Radiol 2009, 70(2):320-324.
21. Hu M., Han A., Xing L., Yang W., Fu Z., Huang C., et al. Value of dual-time-point FDG PET/CT for mediastinal nodal staging innon-small-cell lung cancer patients with lung comorbidity. Clin Nucl Med 2011, 36(6):429-433.
22. Rosen E.L., Eubank W.B., Mankoff D.A. FDG PET PET/CT, and breast cancer imaging. Radiographics 2007, 27(Suppl 1):S215-S229.
23. Schapira D.V., Jarrett A.R. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Adv Intern Med 1995, 155(19):2050-2054.
24. Kwee T.C., Kwee R.M. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 2009, 19(3):731-744.